Success Metrics

Clinical Success Rate

33.3%

Based on 1 completed trials

Completion Rate

33%(1/3)

Active Trials

0(0%)

Results Posted

100%(1 trials)

Terminated

2(40%)

Phase Distribution

Ph not_applicable

40%

Ph phase_4

20%

Ph phase_3

40%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 3Large-scale testing

2(40.0%)

Phase 4Post-market surveillance

1(20.0%)

N/ANon-phased studies

2(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(1)

Terminated(2)

Detailed Status

Not yet recruiting2

Terminated2

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

33.3%

Most Advanced

Phase 4

Trials by Phase

Phase 32 (40.0%)

Phase 41 (20.0%)

N/A2 (40.0%)

Trials by Status

completed120%

not_yet_recruiting240%

terminated240%

Recent Activity

0 active trials

Showing 5 of 5

not_yet_recruitingnot_applicable

Polymethyl Methacrylate and (PEGT/PBT) Centralizer by the Uncemented BIHAPRO THP

NCT00214760

Clinical Trials (5)

Showing 5 of 5 trials

NCT06851494Not Applicable

Safety and Efficacy of Linnea Safe PMMA 30% Use for Gluteal Augmentation.

Not Yet Recruiting

NCT06544304Phase 3

Buttock Augmentation With Polymethylmethacrylate

Not Yet Recruiting

NCT05955222Not Applicable

Clinical Performance of CAD/CAM Splint Materials

Completed

NCT03042546Phase 4

Calcium Sulfate Spacer in Open Tibia Fractures

Terminated

NCT00214760Phase 3

Polymethyl Methacrylate and (PEGT/PBT) Centralizer by the Uncemented BIHAPRO THP

Terminated

All 5 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 5